GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ascelia Pharma AB (OSTO:ACE) » Definitions » Current Deferred Taxes Liabilities

Ascelia Pharma AB (OSTO:ACE) Current Deferred Taxes Liabilities : kr0.00 Mil (As of Mar. 2025)


View and export this data going back to 2019. Start your Free Trial

What is Ascelia Pharma AB Current Deferred Taxes Liabilities?

Current Deferred Taxes Liabilities represent future tax liabilities, resulting from temporary differences between book (accounting) value of assets and liabilities and their tax value, or timing differences between the recognition of gains and losses in financial statements and their recognition in a tax computation. Deferred tax liabilities generally arise where tax relief is provided in advance of an accounting expense, or income is accrued but not taxed until received.

Ascelia Pharma AB's current deferred tax liabilities for the quarter that ended in Mar. 2025 was kr0.00 Mil.

Ascelia Pharma AB Current Deferred Taxes Liabilities Historical Data

The historical data trend for Ascelia Pharma AB's Current Deferred Taxes Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ascelia Pharma AB Current Deferred Taxes Liabilities Chart

Ascelia Pharma AB Annual Data
Trend Jun17 Jun18 Jun19 Dec20 Dec21 Dec22 Dec23 Dec24
Current Deferred Taxes Liabilities
Get a 7-Day Free Trial - - - - -

Ascelia Pharma AB Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Current Deferred Taxes Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Ascelia Pharma AB Current Deferred Taxes Liabilities Related Terms

Thank you for viewing the detailed overview of Ascelia Pharma AB's Current Deferred Taxes Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Ascelia Pharma AB Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ascelia Pharma AB (OSTO:ACE) » Definitions » Current Deferred Taxes Liabilities
Comparable Companies
OSTO:CANTA OSTO:IRLAB A OSTO:XBRANE OSTO:ONCO OSTO:IVACC OSTO:ELIC OSTO:LIPUM OSTO:GUARD OSTO:XINT XSAT:CESSA VRTX ASX:CSL REGN XKRX:207940 ALNY XBRU:ARGX XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
7ZA:Germany
Address
Hyllie Boulevard 34, Malmo, SWE, 215 32
Website
https://www.ascelia.com
Ascelia Pharma AB is a biotech company focused on orphan oncology treatments. The company develops and commercializes novel drugs that address unmet medical needs and have a clear development and market pathway. It has two drug candidates, Orviglance and Oncoral, in development. Orviglance (manganese chloride tetrahydrate) is an oral contrast agent for MR imaging developed to improve the detection and visualization of focal liver lesions (including liver metastases and primary tumors) in patients with impaired kidney function, and Oncoral is a novel oral irinotecan tablet in development.

Ascelia Pharma AB Headlines

No Headlines